Actively Recruiting
Recurrent Visceral Leishmaniasis in HIV Co-Infection
Led by Institute of Tropical Medicine, Belgium · Updated on 2026-03-23
20
Participants Needed
1
Research Sites
110 weeks
Total Duration
On this page
Sponsors
I
Institute of Tropical Medicine, Belgium
Lead Sponsor
A
Armauer Hansen Research Institute, Ethiopia
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients living with HIV and (2) to improve treatment monitoring of this target group in Ethiopia
CONDITIONS
Official Title
Recurrent Visceral Leishmaniasis in HIV Co-Infection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed visceral leishmaniasis by parasite presence in spleen or bone marrow at first episode or relapse, or decision to treat for known active chronic cases
- Confirmed HIV infection, whether new or past
- Age 18 years or older
You will not qualify if you...
- Unwilling to provide written informed consent
- Unwilling to attend follow-up visits
- Mentally or physically unable to participate in the study, as judged by the treating physician
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Gondar
Gonder, Ethiopia
Actively Recruiting
Research Team
N
Nicole Berens-Riha
CONTACT
J
Johan van Griensven
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here